These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 18083354)
1. Vinorelbine and infusional 5-fluorouracil in anthracycline and taxane pre-treated metastatic breast cancer. Stuart NS; McIllmurray MB; Bishop JL; Johnston SR; Price CG; O'Reilly SM; Joffe JK; Neave F; Whipp EC Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):152-6. PubMed ID: 18083354 [TBL] [Abstract][Full Text] [Related]
2. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes. Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644 [TBL] [Abstract][Full Text] [Related]
3. Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes. Kalbakis K; Kouroussis C; Kakolyris S; Mavroudis D; Souglakos J; Agelaki S; Vamvakas L; Christodoulakis M; Stylianou K; Georgoulias V Br J Cancer; 2001 Sep; 85(6):798-802. PubMed ID: 11556827 [TBL] [Abstract][Full Text] [Related]
4. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines. Pieńkowski T; Jagiello-Gruszfeld A Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140 [TBL] [Abstract][Full Text] [Related]
5. Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients. Zelek L; Cottu P; Tubiana-Hulin M; Vannetzel JM; Chollet P; Misset JL; Chouaki N; Marty M; Gamelin E; Culine S; Dieras V; Mackenzie S; Spielmann M J Clin Oncol; 2002 May; 20(10):2551-8. PubMed ID: 12011135 [TBL] [Abstract][Full Text] [Related]
6. A phase II study of an oxaliplatin/vinorelbine/5-fluorouracil combination in patients with anthracycline-pretreated and taxane-pretreated metastatic breast cancer. Delozier T; Guastalla JP; Yovine A; Levy C; Chollet P; Mousseau M; Delva R; Coeffic D; Vannetzel JM; Zazzi ES; Brienza S; Cvitkovic E Anticancer Drugs; 2006 Oct; 17(9):1067-73. PubMed ID: 17001180 [TBL] [Abstract][Full Text] [Related]
7. Second line chemotherapy with 5 fluorouracil and vinorelbine in anthracycline and taxane pretreated patients with metastatic breast cancer. Razis E; Kosmidis P; Aravantinos G; Bakoyiannis C; Janinis J; Timotheadou H; Christodoulou C; Fountzilas G Cancer Invest; 2004; 22(1):10-5. PubMed ID: 15069759 [TBL] [Abstract][Full Text] [Related]
8. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer. Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614 [TBL] [Abstract][Full Text] [Related]
9. Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines. Berruti A; Sperone P; Bottini A; Gorzegno G; Lorusso V; Brunelli A; Botta M; Tampellini M; Donadio M; Mancarella S; De Lena M; Alquati P; Dogliotti L J Clin Oncol; 2000 Oct; 18(19):3370-7. PubMed ID: 11013277 [TBL] [Abstract][Full Text] [Related]
10. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM). Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648 [TBL] [Abstract][Full Text] [Related]
11. Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxane. Verma S; Wong NS; Trudeau M; Joy A; Mackey J; Dranitsaris G; Clemons M Am J Clin Oncol; 2007 Jun; 30(3):297-302. PubMed ID: 17551309 [TBL] [Abstract][Full Text] [Related]
12. Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: a phase II study. Nolè F; Munzone E; Mandalà M; Catania C; Orlando L; Zampino MG; Minchella I; Colleoni M; Peruzzotti G; Marrocco E; Goldhirsch A Ann Oncol; 2001 Jan; 12(1):95-100. PubMed ID: 11249057 [TBL] [Abstract][Full Text] [Related]
13. Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients. Berruti A; Bitossi R; Bottini A; Bonardi S; Donadio M; Nigro C; Bertetto O; Danese S; Bertone E; Sarobba MG; Farris A; Katsaros D; Castiglione F; Volpe T; Lattuada S; Mancarella S; Dogliotti L Eur J Cancer; 2005 Jan; 41(2):249-55. PubMed ID: 15661550 [TBL] [Abstract][Full Text] [Related]
14. Sequential therapy with capecitabine followed by vinorelbine/cisplatin in patients with anthracycline/taxane-refractory metastatic breast cancer. Lin PC; Wang WS; Yang MH; Yen CC; Chao TC; Hsiao LT; Chen PM J Chin Med Assoc; 2006 Jul; 69(7):304-9. PubMed ID: 16903643 [TBL] [Abstract][Full Text] [Related]
15. Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes. Fan Y; Xu B; Yuan P; Wang J; Ma F; Li Q; Zhang P; Li Q; Cai R Chemotherapy; 2010; 56(4):340-7. PubMed ID: 20720418 [TBL] [Abstract][Full Text] [Related]
16. A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer. Karachaliou N; Ziras N; Syrigos K; Tryfonidis K; Papadimitraki E; Kontopodis E; Bozionelou V; Kalykaki A; Georgoulias V; Mavroudis D Cancer Chemother Pharmacol; 2012 Jul; 70(1):169-76. PubMed ID: 22669571 [TBL] [Abstract][Full Text] [Related]
17. Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatment. Vassilomanolakis M; Koumakis G; Demiri M; Missitzis J; Barbounis V; Efremidis AP Cancer Invest; 2003; 21(4):497-504. PubMed ID: 14533438 [TBL] [Abstract][Full Text] [Related]
18. Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study. Schmid P; Heilmann V; Schulz CO; Dieing A; Lehenbauer-Dehm S; Jehn C; Sezer O; Possinger K; Flath B J Cancer Res Clin Oncol; 2005 Sep; 131(9):568-74. PubMed ID: 16044345 [TBL] [Abstract][Full Text] [Related]
19. A Phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes. Estévez LG; Batista N; Sánchez-Rovira P; Velasco A; Provencio M; León A; Dómine M; Cruz J; Rodríguez M Clin Breast Cancer; 2008 Apr; 8(2):149-54. PubMed ID: 18621611 [TBL] [Abstract][Full Text] [Related]
20. Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study. Oliva C; Bergnolo P; Inguì M; Bianco L; Pochettino P; Cutin SC; Boglione A; Dal Canton O; Garetto F; Comandone A J Cancer Res Clin Oncol; 2010 Mar; 136(3):411-7. PubMed ID: 19727815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]